• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌的三维适形放疗与传统方形野技术:一项剂量学观察性研究

3D Conformal Radiotherapy Versus the Conventional Box Technique for Cervical Cancer: A Dosimetric Observational Study.

作者信息

Yadav Jagrati, Gupta Seema, Venugopal Ajay K, Ghosh Arunima, Gupta Indra J

机构信息

Department of Medical Oncology, Jawaharlal Nehru Medical College, Wardha, IND.

Department of Radiation Oncology, King George's Medical University, Lucknow, IND.

出版信息

Cureus. 2025 Aug 11;17(8):e89799. doi: 10.7759/cureus.89799. eCollection 2025 Aug.

DOI:10.7759/cureus.89799
PMID:40937215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12422066/
Abstract

BACKGROUND

Intensity-modulated radiotherapy (IMRT) and 3D-conformal radiotherapy (3D-CRT) have transformed radiation therapy in gynecologic cancers. However, access to advanced techniques in resource-limited settings is constrained. This study proposes a comparative dosimetric analysis using the cervical dosimetry mapping and planning (CERV-DOSIMAP) framework to evaluate the efficacy of 3D-CRT versus the conventional four-field box technique in locally advanced cervical cancer.

METHODS

Radiotherapy planning was performed on 30 individuals with biopsy-confirmed International Federation of Gynaecology and Obstetrics (FIGO) stage IIB-IIIB cervical carcinoma using both conventional and 3D-CRT methods. Using CT-based organizing, volume goals (gross tumor volume (GTV), clinical target volume (CTV), and planning target volume (PTV)) and the organs at risk (OAR) were defined. Dose-volume histogram (DVH) data were analyzed. Key indices such as conformity index (CI), homogeneity index (HI), and dose coverage to PTV and OAR were statistically compared using paired t-tests.

RESULTS

The 3D-CRT demonstrated significantly higher conformity (CI: 0.92 ± 0.03; p=0.001) and better homogeneity (HI: 0.08 ± 0.01; p=0.002) compared to conventional plans (CI: 0.85 ± 0.04; HI: 0.13 ± 0.02; p=0.003). There was a meaningful reduction in bladder, rectum, and femoral head doses with 3D-CRT.

CONCLUSION

The CERV-DOSIMAP framework validates 3D-CRT as a superior alternative to conventional techniques in improving target dose conformity while minimizing exposure to critical pelvic structures.

摘要

背景

调强放射治疗(IMRT)和三维适形放射治疗(3D-CRT)已经改变了妇科癌症的放射治疗方式。然而,在资源有限的环境中,获得先进技术受到限制。本研究提出使用宫颈剂量测定映射和规划(CERV-DOSIMAP)框架进行比较剂量分析,以评估3D-CRT与传统四野盒式技术在局部晚期宫颈癌中的疗效。

方法

对30例经活检确诊为国际妇产科联盟(FIGO)IIB-IIIB期宫颈癌的患者,分别采用传统方法和3D-CRT方法进行放射治疗计划。通过基于CT的组织分析,定义了体积目标(大体肿瘤体积(GTV)、临床靶体积(CTV)和计划靶体积(PTV))以及危及器官(OAR)。分析剂量体积直方图(DVH)数据。使用配对t检验对适形指数(CI)、均匀性指数(HI)以及PTV和OAR的剂量覆盖等关键指标进行统计学比较。

结果

与传统计划(CI:0.85±0.04;HI:0.13±0.02;p=0.003)相比,3D-CRT显示出显著更高的适形性(CI:0.92±0.03;p=0.001)和更好的均匀性(HI:0.08±0.01;p=0.002)。3D-CRT使膀胱、直肠和股骨头的剂量有了显著降低。

结论

CERV-DOSIMAP框架验证了3D-CRT是传统技术的一种更好替代方案,可提高靶区剂量适形性,同时将关键盆腔结构的受照剂量降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/12422066/b53ec0452b02/cureus-0017-00000089799-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/12422066/b53ec0452b02/cureus-0017-00000089799-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d24/12422066/b53ec0452b02/cureus-0017-00000089799-i01.jpg

相似文献

1
3D Conformal Radiotherapy Versus the Conventional Box Technique for Cervical Cancer: A Dosimetric Observational Study.宫颈癌的三维适形放疗与传统方形野技术:一项剂量学观察性研究
Cureus. 2025 Aug 11;17(8):e89799. doi: 10.7759/cureus.89799. eCollection 2025 Aug.
2
Efficacy of hydrogel spacer compared with intensity-modulated radiotherapy for 3-dimensional conformal radiotherapy for prostate cancer.水凝胶间隔物与调强放疗用于前列腺癌三维适形放疗的疗效比较
Med Dosim. 2025;50(3):203-208. doi: 10.1016/j.meddos.2025.01.005. Epub 2025 Feb 1.
3
Evaluation of the efficacy of automated machine learning enhanced planning system and a comparative analysis with manual planning system.自动化机器学习增强型计划系统的疗效评估及与手动计划系统的对比分析。
J Cancer Res Ther. 2025 Apr 1;21(3):593-601. doi: 10.4103/jcrt.jcrt_1373_24. Epub 2025 Jul 5.
4
Converging lens radiotherapy (CLRT) employing kilovoltage x-ray source: Treatment planning study.采用千伏级X射线源的会聚透镜放射治疗(CLRT):治疗计划研究
Med Phys. 2025 Aug;52(8):e18007. doi: 10.1002/mp.18007.
5
Assessment and Comparison of 3D Conformal Radiotherapy With Volumetric Modulated Arc Therapy for Preserving Remaining Brain Volume in High-Grade Gliomas.三维适形放疗与容积调强弧形放疗在保留高级别胶质瘤剩余脑容积方面的评估与比较
Cureus. 2025 Aug 4;17(8):e89335. doi: 10.7759/cureus.89335. eCollection 2025 Aug.
6
The impact of body mass index on radiotherapy technique in patients with early-stage endometrial cancer: a single-center dosimetric study.
Int J Gynecol Cancer. 2014 Nov;24(9):1607-15. doi: 10.1097/IGC.0000000000000298.
7
Intensity-modulated Radiotherapy Versus Volumetric Modulated Arc Therapy in Head and Neck Cancers: A Comparative Analysis of Compliance, Toxicities and Dosimetric Parameters.调强放射治疗与容积调强弧形治疗在头颈癌中的应用:依从性、毒性和剂量学参数的比较分析
Cureus. 2025 Jun 16;17(6):e86143. doi: 10.7759/cureus.86143. eCollection 2025 Jun.
8
Evaluation of the liver load index as a predictor of liver exposure in right breast radiotherapy.评估肝脏负荷指数作为右乳放疗中肝脏暴露预测指标的价值。
Rep Pract Oncol Radiother. 2025 Aug 7;30(3):306-315. doi: 10.5603/rpor.105864. eCollection 2025.
9
Dosimetric comparison of hybrid IMRT and different arc techniques VMAT after breast-conserving surgery for left-sided breast cancer.左侧乳腺癌保乳术后混合调强放疗与不同弧形技术容积调强弧形放疗的剂量学比较
J Appl Clin Med Phys. 2025 Sep;26(9):e70257. doi: 10.1002/acm2.70257.
10
Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for cervical cancer in resource-limited settings.资源有限环境下钴-60高剂量率近距离放射治疗宫颈癌的剂量学评估与不确定性分析
J Cancer Res Clin Oncol. 2025 Sep 9;151(9):247. doi: 10.1007/s00432-025-06280-0.

本文引用的文献

1
Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications.人乳头瘤病毒驱动的宫颈癌的分子见解:癌蛋白、免疫逃逸和表观遗传修饰
Microorganisms. 2025 Apr 27;13(5):1000. doi: 10.3390/microorganisms13051000.
2
Current Paradigm and Future Directions in the Management of Nodal Disease in Locally Advanced Cervical Cancer.局部晚期宫颈癌淋巴结疾病管理的当前范式与未来方向
Cancers (Basel). 2025 Jan 9;17(2):202. doi: 10.3390/cancers17020202.
3
Synthesizing Efficiency Tools in Radiotherapy to Increase Patient Flow: A Comprehensive Literature Review.
综合放疗中的效率工具以增加患者流量:一项全面的文献综述。
Clin Med Insights Oncol. 2024 Dec 13;18:11795549241303606. doi: 10.1177/11795549241303606. eCollection 2024.
4
Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types.保留生育功能手术后宫颈癌复发的风险及人乳头瘤病毒感染类型的作用
J Clin Med. 2024 Oct 22;13(21):6318. doi: 10.3390/jcm13216318.
5
Weekly Image Guidance in Patients With Cervical Cancer Treated With Intensity-Modulated Radiation Therapy: Results of a Large Cohort Study.《接受调强放疗的宫颈癌患者每周影像引导:一项大型队列研究结果》。
Cancer Med. 2024 Sep;13(18):e70269. doi: 10.1002/cam4.70269.
6
Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer.调强放疗(IMRT)对转移性宫颈癌远处转移淋巴结的临床意义。
BMC Cancer. 2024 Sep 20;24(1):1170. doi: 10.1186/s12885-024-12895-2.
7
Challenges and Opportunities in Accessing Surgery for Glioblastoma in Low-Middle Income Countries: A Narrative Review.低收入和中等收入国家胶质母细胞瘤手术可及性面临的挑战与机遇:一项叙述性综述
Cancers (Basel). 2024 Aug 17;16(16):2870. doi: 10.3390/cancers16162870.
8
New Frontiers in Locally Advanced Cervical Cancer Treatment.局部晚期宫颈癌治疗的新前沿
J Clin Med. 2024 Jul 30;13(15):4458. doi: 10.3390/jcm13154458.
9
Improvement of treatment plan quality with modified fixed field volumetric modulated arc therapy in cervical cancer.改良固定野容积旋转调强放疗在宫颈癌治疗计划中的质量改进。
J Appl Clin Med Phys. 2024 Oct;25(10):e14479. doi: 10.1002/acm2.14479. Epub 2024 Jul 20.
10
The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice.程序性细胞死亡免疫检查点抑制剂(抗PD-1)及其配体(抗PD-L1)的选择给临床实践带来了更多挑战。
Taiwan J Obstet Gynecol. 2024 Jul;63(4):448-450. doi: 10.1016/j.tjog.2024.05.004.